Maviret, Eloctate & Alprolix newly registered for health insurance benefits from 1 June
Chronic hepatitis C treatment Maviret and hemophilia treatments Eloctate & Alprolix will newly be added to the list of health insurance benefits from 1 June.
Sovaldi Tab and Harvoni Tab will voluntarily drop their price by half.
The Ministry of Health and Welfare has revised and issued the ‘Dru...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.